APA
Phillips K., Milne R. L., Rookus M. A., Daly M. B., Antoniou A. C., Peock S., Frost D., Easton D. F., Ellis S., Friedlander M. L., Buys S. S., Andrieu N., Noguès C., Stoppa-Lyonnet D., Bonadona V., Pujol P., McLachlan S. A., John E. M., Hooning M. J., Seynaeve C., Tollenaar R. A. E. M., Goldgar D. E., Terry M. B., Caldes T., Weideman P. C., Andrulis I. L., Singer C. F., Birch K., Simard J., Southey M. C., Olsson H. L., Jakubowska A., Olah E., Gerdes A., Foretova L. & Hopper J. L. (20131029). Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Chicago
Phillips Kelly-Anne, Milne Roger L, Rookus Matti A, Daly Mary B, Antoniou Antonis C, Peock Susan, Frost Debra, Easton Douglas F, Ellis Steve, Friedlander Michael L, Buys Saundra S, Andrieu Nadine, Noguès Catherine, Stoppa-Lyonnet Dominique, Bonadona Valérie, Pujol Pascal, McLachlan Sue Anne, John Esther M, Hooning Maartje J, Seynaeve Caroline, Tollenaar Rob A E M, Goldgar David E, Terry Mary Beth, Caldes Trinidad, Weideman Prue C, Andrulis Irene L, Singer Christian F, Birch Kate, Simard Jacques, Southey Melissa C, Olsson Håkan L, Jakubowska Anna, Olah Edith, Gerdes Anne-Marie, Foretova Lenka and Hopper John L. 20131029. Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Harvard
Phillips K., Milne R. L., Rookus M. A., Daly M. B., Antoniou A. C., Peock S., Frost D., Easton D. F., Ellis S., Friedlander M. L., Buys S. S., Andrieu N., Noguès C., Stoppa-Lyonnet D., Bonadona V., Pujol P., McLachlan S. A., John E. M., Hooning M. J., Seynaeve C., Tollenaar R. A. E. M., Goldgar D. E., Terry M. B., Caldes T., Weideman P. C., Andrulis I. L., Singer C. F., Birch K., Simard J., Southey M. C., Olsson H. L., Jakubowska A., Olah E., Gerdes A., Foretova L. and Hopper J. L. (20131029). Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
MLA
Phillips Kelly-Anne, Milne Roger L, Rookus Matti A, Daly Mary B, Antoniou Antonis C, Peock Susan, Frost Debra, Easton Douglas F, Ellis Steve, Friedlander Michael L, Buys Saundra S, Andrieu Nadine, Noguès Catherine, Stoppa-Lyonnet Dominique, Bonadona Valérie, Pujol Pascal, McLachlan Sue Anne, John Esther M, Hooning Maartje J, Seynaeve Caroline, Tollenaar Rob A E M, Goldgar David E, Terry Mary Beth, Caldes Trinidad, Weideman Prue C, Andrulis Irene L, Singer Christian F, Birch Kate, Simard Jacques, Southey Melissa C, Olsson Håkan L, Jakubowska Anna, Olah Edith, Gerdes Anne-Marie, Foretova Lenka and Hopper John L. Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20131029.